GSK plc (NYSE: GSK) plans Deloitte re-appointment as external auditor from 2028
Rhea-AI Filing Summary
GSK plc announces that, following a competitive tender process led by its Audit & Risk Committee, the Board has decided to re-appoint Deloitte LLP as external auditor from the financial year ending 31 December 2028. Deloitte was initially appointed for the financial year ended 31 December 2018.
As a Public Interest Entity, GSK is required to tender its statutory audit every 10 years and rotate auditor every 20 years. A resolution to re-appoint Deloitte with effect from the 2028 financial year will be put to shareholders for approval at the 2028 Annual General Meeting, with further details to appear in GSK’s 2026 Annual Report.
Positive
- None.
Negative
- None.
Key Figures
Audit tender frequency: every 10 years
Audit rotation requirement: every 20 years
Start of new Deloitte term: financial year ending 31 December 2028
+1 more
4 metrics
Audit tender frequency
every 10 years
Requirement for GSK as a Public Interest Entity to tender statutory audit
Audit rotation requirement
every 20 years
Requirement for GSK as a Public Interest Entity to rotate external auditor
Start of new Deloitte term
financial year ending 31 December 2028
Planned effective year of Deloitte’s re-appointment as external auditor
Initial Deloitte appointment year
financial year ended 31 December 2018
Year Deloitte was first appointed as GSK’s external auditor
Key Terms
Public Interest Entity, statutory audit, competitive tender process, Annual General Meeting
4 terms
Public Interest Entity regulatory
"As a Public Interest Entity, GSK is required to tender the statutory audit"
statutory audit regulatory
"GSK is required to tender the statutory audit every 10 years"
competitive tender process financial
"after the conclusion of a competitive tender process led by the Audit & Risk Committee"
Annual General Meeting regulatory
"approval at the Company's 2028 Annual General Meeting"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did GSK (GSK) decide regarding its external auditor?
GSK’s Board decided to re-appoint Deloitte LLP as its external auditor from the financial year ending 31 December 2028, following a competitive tender process led by the Audit & Risk Committee, subject to shareholder approval at the 2028 Annual General Meeting.
When will Deloitte’s re-appointment as GSK (GSK) auditor take effect?
Deloitte’s re-appointment is intended to take effect from GSK’s financial year ending 31 December 2028. A resolution for this re-appointment will be presented to shareholders for approval at the company’s 2028 Annual General Meeting.
What audit tender and rotation rules apply to GSK (GSK)?
As a Public Interest Entity, GSK is required to tender its statutory audit every 10 years and rotate its external auditor every 20 years. The competitive tender concluding in Deloitte’s planned re-appointment reflects these regulatory obligations.
When was Deloitte first appointed as GSK (GSK) external auditor?
Deloitte was first appointed as GSK’s external auditor with effect from the financial year ended 31 December 2018. The new decision extends that relationship, subject to shareholder approval, from the 2028 financial year onward.
Where will more details on GSK (GSK) audit tender be provided?
Further details of GSK’s competitive audit tender process will be included in the company’s 2026 Annual Report. This report is expected to describe the tender approach and considerations behind the Board’s decision to retain Deloitte.